Use of Outpatient-Derived COVID-19 Convalescent Plasma in COVID-19 Patients Before Seroconversion

BACKGROUND: Transfusion of COVID-19 convalescent plasma (CCP) containing high titers of anti-SARS-CoV-2 antibodies serves as therapy for COVID-19 patients. Transfusions early during disease course was found to be beneficial. Lessons from the SARS-CoV-2 pandemic could inform early responses to future...

Descripción completa

Detalles Bibliográficos
Autores principales: Wirz, Oliver F., Röltgen, Katharina, Stevens, Bryan A., Pandey, Suchitra, Sahoo, Malaya K., Tolentino, Lorna, Verghese, Michelle, Nguyen, Khoa, Hunter, Molly, Snow, Theo Thomas, Singh, Abhay Raj, Blish, Catherine A., Cochran, Jennifer R., Zehnder, James L., Nadeau, Kari C., Pinsky, Benjamin A., Pham, Tho D., Boyd, Scott D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477649/
https://www.ncbi.nlm.nih.gov/pubmed/34594341
http://dx.doi.org/10.3389/fimmu.2021.739037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477649/
https://www.ncbi.nlm.nih.gov/pubmed/34594341
http://dx.doi.org/10.3389/fimmu.2021.739037

Ejemplares similares